Public value judgments about the criteria for reimbursement of medicines in South Korea

Which factor reduces pharmaceutical expenditure, number of entrants or price variance? Updated generic drug markets in South Korea

Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?

Tightened social distancing measures and increased violence during the COVID-19 pandemic in South Korea

Impact of the COVID-19 Pandemic on the Public Perceptions of the Roles and Functions of Community Pharmacies in South Korea: Updated Cross-Sectional Self-Reported Web-Based Survey

Patenting and patent challenges in South Korea after introducing a patent linkage system

Who initiates price competition when generic entrants are introduced into the South Korean pharmaceutical market?

Understanding patient and physician responses to various cost-sharing programs for prescription drugs in South Korea: A multilevel analysis

Perceptions of Regulatory Decision-Making for New Drugs From the Viewpoints of the Manufacturers in South Korea

The impact of COVID-19 on the number of active small primary care businesses by severity of the pandemic: evidence from South Korea